TABLE 3.
miRNAs and lncRNAs regulated by Wnt pathway in various cancer types.
| miRNAs | |||
| Cancer type | Upregulated | Downregulated | References |
| CRC | miR-708, miR-31, miR-135b, miR-21, miR-182, miR574-3p, miR-30e | miR-215, miR-137 | Liao and Lönnerdal, 2010; Lan et al., 2012; Chiang et al., 2013; Necela et al., 2011 |
| GC | miR-20a-3p, miR-23b-5p, miR-335-3p, miR-423-5p, miR-455-3p | miR-1234-3p, miR-135b-5p, miR-210, miR4739, miR-122a | Wang et al., 2009; Dong et al., 2015 |
| HCC | miR-770, miR-183, miR-96, miR-182 | miR-375 | Ladeiro et al., 2008; Leung et al., 2015; Wu et al., 2016 |
| BC | miR-182, miR-125b | Let-7 | Cai et al., 2013; Chiang et al., 2013; Liu et al., 2013 |
| IncRNAs | |||
| Cancer Type | IncRNAs | Outcome | References |
| CRC | KIAA0125 | Downregulated | Yang Y. et al., 2019 |
| CC | CALML3-AS1 | Upregulated | Liu et al., 2019 |
| BC | LUCAT1 | Upregulated | Zheng et al., 2019 |
| LC | LINC00673-v4 | Upregulated | Lin et al., 2020 |
| LC | AK126698 | Downregulated | Fu et al., 2016 |
| Pituitary adenoma | CLRN1-AS1 | Downregulated | Wang et al., 2019 |
| Glioma | SNHG17, MIR22HG, HOXC13-AS, LSINCT5, H19, BLACAT1, SNHG5, LINC01503, AGAP2-AS1, OIP5-AS1, DANCR, SNHG7, NEAT1, AB073614, MIR155HG, CCND2-AS1, CCAT2 and MALAT1 | Upregulated | Han et al., 2020 |
| Glioma | CASC7, Linc00320, TUNAR, MEG3, CASC2 and PTCSC3 | Downregulated | Han et al., 2020 |
| Colon cancer | CCAT2 | Upregulated | Ling et al., 2013 |
| LC | LINC00673-v4 | Upregulated | Guan et al., 2019 |
| Liver cancer | TCF7 | Upregulated | Wang et al., 2015 |
CRC, colorectal cancer; CLL, chronic lymphocytic leukemia; BC, breast cancer; HCC, hepatocellular carcinoma; OC, ovarian cancer; CC, cervical cancer; GC, gastric cancer; HNSCC, head and neck squamous cell carcinoma; RCC, renal cell carcinoma; LC, lung cancer; PC, pancreatic cancer; OS, osteosarcoma.